The McGill University Department of Pathology is located in the Duff Medical Building on the downtown University campus at the edge of splendid Mount Royal. The Department offers research training in a wide variety of areas such as carcinogenesis, mechanisms of respiratory diseases, molecular pathology and immunology, neoplasia and cell biology, cell differentiation, cell adhesion molecules, biomedical image processing, neurodegenerative disorders and opthalmic pathology. Research laboratories are located in the Duff Medical Building, the Research Institute of the McGill University Health Centre and McGill Teaching Hospitals.
Message from the Chair
We are very pleased to announce the appointment of Dr. Chelsea Maedler-Kron as Program Director and Dr. Pierre Olivier Fiset as Associate Program Director for the Anatomical Pathology Residency Training Program in the McGill University Department of Pathology effective July1st, 2020, for an initial term of four years with the possibility of renewal. The appointment has been unanimously supported by the Departmental Academic Committee and officially approved by Dr. Armand Aalamian, the Associate Dean of Postgraduate Medical Education.
Dr. Maedler-Kron obtained her MD degree at the McMaster University, anatomical pathology residency at McGill and Dalhousie University, and pediatric pathology fellowship at the University of Southern California. Her excellent career path is evidenced by 25 prestigious awards in research and education such as the CIHR Banting & Best Doctoral Research Award. During her residency at McGill, she spearheaded the creation and implementation of a ‘transition to pathology’ rotation for PGY1 residents and the multiple mini interview for CaRMS resident selection. She was the resident representative on the Pathology Specialty Committee on Competence by Design (CBD) of the Royal College (2016-17). She helped the creation of ‘Milestones’ and ‘EPA’ working group documents for Anatomic Pathology at the national CBD committee. Since joining McGill as a staff pathologist, she worked tirelessly as the leader of CBD implementation in our department. As the program director, Dr. Maedler-Kron will be responsible for 60% of the administrative task of the program to ensure our department is leading the country on the implementation of CBD training curriculum.
Dr. Pierre Olivier Fiset obtained his MD degree, PhD degree, and anatomical pathology residency at McGill, and thoracic pathology fellowship at the University of Toronto. He was the winner of the Resident Teacher of the Year Award in 2012 and Staff Teacher of the Year Award in 2018. During his residency at McGill, he designed the website for our Pathology Residency Training program, created the McGill digital slide teaching library using the Aperio ScanScope system, and involved in demonstrating to a general audience how pathologists diagnose disease. Since joining McGill as a staff pathologist, he was a member of the CaRMS selection committee, resident training committee, award selection committee, and the departmental academic committee. In May 2019, he took on the role as the research director in the residency-training program. Dr. Fiset has established a very successful research career with 40 articles published in prestigious peer-reviewed journals. Under his supervision, three resident’s manuscripts were submitted and several are in preparation. As Associate Program Director, Dr. Fiset will be responsible for 40% of the administrative task with primary focus of research and innovation.
Finally, I would like to use this opportunity to thank our co-program directors Dr. Jason Karamchandani and Dr. Van-Hung Nguyen for their dedicated leadership and contributions to our Residency Training Program. Under their leadership, our program was accredited by the Royal College for another 7 years. All of our senior residents passed the Royal College Exam and went on to successful careers. Our CaRMS match has been successful to recruit excellent candidates into our program. Our program raised more than 400,000 dollars in educational funding for the purchase of teaching equipment and supplies. For the last several years, McGill has presented postgraduate innovations and matching experiences at the national CAP-ACP meeting. Our residents have produced many high impact publications and have won many awards at the national CAP-ACP and international USCAP meetings. Our program has attracted hundreds of medical students, residents, and fellows from other universities, who have pursued electives and rotations in our department.
Please join me to thank Dr. Jason Karamchandani and Dr. Van-Hung Nguyen, and welcome Dr. Chelsea Maedler-Kron and Dr. Pierre Olivier Fiset. With this great succession, I am confident that McGill Anatomical Pathology Residency Training Program with continue to be one the best training program in the world.
Drs Spatz, Fiset, Wang, and Camilleri-Broet from the Department of Pathology are at the core of the innovative research project “The Karen Anthony Consortium for Lung Cancer Research”Published: 2 Oct 2020
Dr. Miguel Burnier has been appointed the Interim Executive Director and Chief Scientific Officer of the Research Institute of the McGill University Health Centre (RI-MUHC)Published: 24 Aug 2020
Our PhD student Christina Mastromonaco is a pioneer in the Life Sciences Entrepreneurship Development Program at ConcordiaPublished: 6 Nov 2019
- Published: 2 Oct 2019
- Published: 2 Jul 2019
- Published: 2 Jul 2019
Congratulations to Professor Alan Spatz on receiving GAPP-Genome Canada and Cancer Research Society grantsPublished: 10 Dec 2018
Our graduate student Jade Lasiste was awarded at the Association for Research in Vision and Ophthalmology (ARVO) 2017 in BaltimoPublished: 19 May 2017
- Published: 10 Apr 2017
- Published: 10 Apr 2017
McGill Case of the month
Current Case of the Month ---January 2020
Previous Case of the Month
Publication of the month
Julien LA, Michel RP, Auger M : Breast implant-associated anaplastic large cell lymphoma and effusions: A review with emphasis on the role of cytopathology. Cancer Cytopathol. 2020 Jan 3.
Pusztaszeri MP, Bongiovanni M, Brimo F: Do we need PD-L1 as a biomarker for thyroid cytologic and histologic specimens? Cancer Cytopathol. 2019 Dec 10
Bustamante P1... Burnier JV. Beta-blockers exert potent anti-tumor effects in cutaneous and uveal melanoma. Cancer Med. 2019 Oct 7.
Ferreira SR...: Prenatally androgenized female rats develop uterine hyperplasia when adult. Mol Cell Endocrinol. 2019 Oct 4:110610.
Sharifi Z...Sabri S: Antitumor Activity of a Binary EGFR/DNA Targeting Strategy Overcomes Resistance of Glioblastoma Stem cells to Temozolomide. Clin Cancer Res. 2019 Sep 20.